Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Markus Sieger currently holds 347,100 shares of Cyclo Therapeutics, Inc. (CYTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Markus Sieger has been a net buyer of CYTH stock. They have purchased $576.8K and sold $0 worth of shares.
Markus Sieger's most recent insider trade was on Aug 16, 2024, when they sold 18,354 shares at $0.00 per share.
Markus Sieger serves as Executive at Cyclo Therapeutics, Inc. (CYTH). They have executed 38 insider transactions totaling $576.8K over their tenure at the company.
Markus Sieger holds the position of Executive at Cyclo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Markus Sieger has shown a buying trading pattern, with $576.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Markus Sieger was on Feb 19, 2014, when they purchased $175.0K worth of CTDH shares. This transaction involved 3,500,000 shares at $0.05 per share.
Markus Sieger currently owns 347,100 shares of Cyclo Therapeutics, Inc. (CYTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Markus Sieger's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Markus Sieger has 38 Form 4 filings on record as an insider at Cyclo Therapeutics, Inc..
Set alerts for Markus Sieger and 40,000+ other insiders.